Earnings
TJX Posts Strong Q3 Results and Raises Full-Year Targets
TJX posted Q3 EPS of $1.28 on $15.1 billion in revenue, beating expectations and prompting the company to raise its FY26 guidance.
BTC$62,550.00+1.79%
ETH$1,756.59+3.70%
USDT$0.9991+0.02%
USDC$0.9999+0.02%
XRP$1.13+4.56%
SOL$82.28+2.20%
TRX$0.3226+1.69%
FIGR_HELOC$1.01-2.89%
HYPE$70.84+7.66%
DOGE$0.0775+5.22%
RAIN$0.0155-0.39%
USDS$0.9998+0.01%
LEO$9.16+0.34%
ZEC$463.09+7.37%
XLM$0.2045+3.83%
BTC$62,550.00+1.79%
ETH$1,756.59+3.70%
USDT$0.9991+0.02%
USDC$0.9999+0.02%
XRP$1.13+4.56%
SOL$82.28+2.20%
TRX$0.3226+1.69%
FIGR_HELOC$1.01-2.89%
HYPE$70.84+7.66%
DOGE$0.0775+5.22%
RAIN$0.0155-0.39%
USDS$0.9998+0.01%
LEO$9.16+0.34%
ZEC$463.09+7.37%
XLM$0.2045+3.83%
TJX, Lowe’s, and United Therapeutics reported quarterly results that topped expectations, highlighting steady growth across retail and biotech.
TJX posted Q3 EPS of $1.28 on $15.1 billion in revenue, beating expectations and prompting the company to raise its FY26 guidance.
The TJX Companies, Inc. (NYSE: TJX) reported net sales of $16.4 billion for the fourth quarter of Fiscal 2025.
The TJX Companies, Inc. (NYSE: TJX) reported a robust performance for the third quarter of Fiscal Year 2025.
TJX reported an EPS of $1.03 and revenue of $13.3 billion for the third quarter.